Danimer Scientific Inc. (DNMR)
OTC: DNMR
· Real-Time Price · USD
0.35
0.00 (0.00%)
At close: Mar 18, 2025, 3:58 PM
Danimer Scientific Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8.63M | 7.63M | 10.22M | 10.95M | 10.95M | 12.87M | 11.93M | 15.32M | 10.45M | 12.7M | 14.74M | 17.73M | 13.37M | 14.47M | 13.18M |
Cost of Revenue | 15.95M | 14.53M | 18.92M | 19.54M | 18.68M | 19.43M | 18.21M | 18.03M | 14.5M | 14.93M | 16.07M | 20.08M | 13.6M | 12.46M | 11.72M |
Gross Profit | -7.32M | -6.9M | -8.7M | -8.59M | -7.74M | -6.57M | -6.28M | -2.7M | -4.05M | -2.23M | -1.32M | -2.35M | -232K | 2.01M | 1.46M |
Operating Income | -18.82M | -19.33M | -18.52M | -30.83M | -31.24M | -31.12M | -32.23M | -29.72M | 35.07M | -32.12M | -30.69M | -35.28M | -31.83M | -21.08M | -11.28M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 9.16M | 3.39M | 474K | 553K | n/a | n/a | n/a | 82K | 19K | 52K |
Pretax Income | -21.84M | -22.66M | -27.26M | -39.43M | -39.69M | -39.3M | -36.73M | -28.09M | -95.11M | -30.68M | -26.68M | -14.26M | -3.6M | 39.25M | -94.73M |
Net Income | -21.84M | -22.66M | -27.26M | -39.43M | -40.16M | -39.24M | -36.64M | -28.05M | -94.88M | -30.45M | -26.39M | -12.45M | 7.83M | 39.25M | -94.73M |
Selling & General & Admin | 6.86M | 6.75M | 6.52M | 16.56M | 16.55M | 16.84M | 18.7M | 19.55M | 19.41M | 20.98M | 22.24M | 24.21M | 26.59M | 19.08M | 10.12M |
Research & Development | 4.58M | 5.11M | 3.31M | 5.68M | 6.88M | 7.71M | 7.08M | 7.47M | 7.95M | 8.91M | 7.13M | 8.67M | 5.01M | 3.98M | 2.62M |
Other Expenses | 65K | 565K | n/a | 200K | 64K | n/a | 170K | 399K | 240K | 75K | 9K | -62K | 90K | 30K | 50K |
Operating Expenses | 11.51M | 12.43M | 9.83M | 22.24M | 23.5M | 24.55M | 25.77M | 27.02M | 27.36M | 29.89M | 29.37M | 32.88M | 31.6M | 23.05M | 12.74M |
Interest Expense | n/a | 9.07M | n/a | 8.51M | 8.68M | 9.26M | 4.5M | n/a | 130.18M | n/a | n/a | 247K | 246K | 222K | 200K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.45M | 26.96M | 28.75M | 41.78M | 42.19M | 43.99M | 43.98M | 45.04M | 41.86M | 44.82M | 45.43M | 52.96M | 45.2M | 35.51M | 24.46M |
Income Tax Expense | 2K | 2K | 2K | 2K | 468K | -61K | -90K | -43K | -236K | -240K | -291K | -1.81M | -11.42M | -60.48M | 83.3M |
Shares Outstanding (Basic) | 119.71M | 116.47M | 103.97M | 102.14M | 102.03M | 101.94M | 101.9M | 101.4M | 100.93M | 101.05M | 100.73M | 100.36M | 98.16M | 88.81M | 84.71M |
Shares Outstanding (Diluted) | 119.71M | 116.47M | 103.97M | 102.14M | 102.03M | 101.94M | 101.9M | 101.4M | 101.2M | 101.05M | 100.73M | 100.36M | 103.52M | 101.52M | 84.71M |
EPS (Basic) | -0.18 | -0.19 | -0.26 | -0.39 | -0.39 | -0.38 | -0.36 | -0.28 | -0.94 | -0.3 | -0.26 | -0.12 | 0.08 | 0.44 | -1.12 |
EPS (Diluted) | -0.18 | -0.19 | -0.26 | -0.39 | -0.39 | -0.38 | -0.36 | -0.28 | -0.94 | -0.3 | -0.26 | -0.12 | 0.08 | 0.39 | -1.12 |
EBITDA | -18.82M | -6.15M | -10.99M | -23.46M | -23.92M | -22.97M | -24.48M | -22.44M | -26.83M | -27.89M | -26.43M | -31.05M | -31.83M | -18.83M | -9.18M |
EBIT | -18.76M | -13.59M | -18.52M | -30.83M | -31.18M | -30.14M | -32.06M | -29.72M | -31.41M | -32.12M | -30.69M | -35.23M | -31.83M | -21.04M | -11.28M |
Depreciation & Amortization | n/a | 7.44M | 7.53M | 7.37M | 7.25M | 7.17M | 7.58M | 7.28M | 4.58M | 4.33M | 4.26M | 4.18M | 3.18M | 2.21M | 2.1M |